SEARCH

SEARCH BY CITATION

References

  • Bertrand Y, Currie JC, Poirier J, Demeule M, Abulrob A, Fatehi D, Stanimirovic D, Sartelet H, Castaigne JP, Beliveau R. 2011. Influence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1. Br. J. Cancer 105(11): 16971707.
  • Boyd MR, Paull KD. 1995. Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen. Drug Devl. Res. 34(2): 91109.
  • Campana WM, Li X, Dragojlovic N, Janes J, Gaultier A, Gonias SL. 2006. The low-density lipoprotein receptor-related protein is a pro-survival receptor in Schwann cells: possible implications in peripheral nerve injury. J. Neurosci. 26(43): 1119711207.
  • Cha TL, Qiu L, Chen CT, Wen Y, Hung MC. 2005. Emodin down-regulates androgen receptor and inhibits prostate cancer cell growth. Cancer Res. 65(6): 22872295.
  • Chen Q, Espey MG, Krishna MC, Mitchell JB, Corpe CP, Buettner GR, Shacter E, Levine M. 2005. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc. Natl. Acad. Sci. U.S.A. 102(38): 1360413609.
  • Chen S, Bu G, Takei Y, Sakamoto K, Ikematsu S, Muramatsu T, Kadomatsu K. 2007. Midkine and LDL-receptor-related protein 1 contribute to the anchorage-independent cell growth of cancer cells. J. Cell Sci. 120(Pt 22): 40094015.
  • Chen YC, Shen SC, Lee WR, Hsu FL, Lin HY, Ko CH, Tseng SW. 2002. Emodin induces apoptosis in human promyeloleukemic HL-60 cells accompanied by activation of caspase 3 cascade but independent of reactive oxygen species production. Biochem. Pharmacol. 64(12): 17131724.
  • Chun-Guang W, Jun-Qing Y, Bei-Zhong L, Dan-Ting J, Chong W, Liang Z, Dan Z, Yan W. 2010. Anti-tumor activity of emodin against human chronic myelocytic leukemia K562 cell lines in vitro and in vivo. Eur. J. Pharmacol. 627(1–3): 3341.
  • Dandekar DS, Lokeshwar BL. 2005. Emodin synergistically enhances docetaxel induced apoptosis in androgen-responsive prostate cancer cells. AACR Meeting Abstr. 2005(1): 723b.
  • Desbordes SC, Placantonakis DG, Ciro A, Socci ND, Lee G, Djaballah H, Studer L. 2008. High-throughput screening assay for the identification of compounds regulating self-renewal and differentiation in human embryonic stem cells. Cell Stem Cell 2(6): 602612.
  • Dikshit R, Gupta PC, Ramasundarahettige C, Gajalakshmi V, Aleksandrowicz L, Badwe R, Kumar R, Roy S, Suraweera W, Bray F et al. 2012. Cancer mortality in India: a nationally representative survey. Lancet 379(9828): 3404534053.
  • Fromberg A, Gutsch D, Schulze D, Vollbracht C, Weiss G, Czubayko F, Aigner A. 2011. Ascorbate exerts anti-proliferative effects through cell cycle inhibition and sensitizes tumor cells towards cytostatic drugs. Cancer Chemother. Pharmacol. 67(5): 11571166.
  • Fuentealba RA, Liu Q, Kanekiyo T, Zhang J, Bu G. 2009. Low density lipoprotein receptor-related protein 1 promotes anti-apoptotic signaling in neurons by activating Akt survival pathway. J. Biol. Chem. 284(49): 3404534053.
  • Furlan D, Sahnane N, Carnevali I, Cerutti R, Uccella S, Bertolini V, Maria Chiaravalli A, Capella C. 2007. Up-regulation and stabilization of HIF-1α in colorectal carcinomas. Surg. Oncol. 16: 2527.
  • Galati G, O'Brien PJ. 2004. Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties. Free Radical Biol. Med. 37(3): 287303.
  • Goldberg MA, Schneider TJ. 1994. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J. Biol. Chem. 269(6): 43554359.
  • Grossmann ME, Huang H, Tindall DJ. 2001. Androgen receptor signaling in androgen-refractory prostate cancer. J. Natl. Cancer Inst. 93(22): 16871697.
  • Hickman JA. 1992. Apoptosis induced by anticancer drugs. Cancer Metastas. Rev. 11(2): 121139.
  • Hsu CM, Hsu YA, Tsai Y, Shieh FK, Huang SH, Wan L, Tsai FJ. 2010. Emodin inhibits the growth of hepatoma cells: finding the common anti-cancer pathway using Huh7, Hep3B, and HepG2 cells. Biochem. Biophys. Res. Commun. 392(4): 473478.
  • Huang Q, Shen HM, Ong CN. 2005. Emodin inhibits tumor cell migration through suppression of the phosphatidylinositol 3-kinase-Cdc42/Rac1 pathway. Cell. Mol. Life Sci. 62(10): 11671175.
  • Huang XZ, Wang J, Huang C, Chen YY, Shi GY, Hu QS, Yi J. 2008. Emodin enhances cytotoxicity of chemotherapeutic drugs in prostate cancer cells: the mechanisms involve ROS-mediated suppression of multidrug resistance and hypoxia inducible factor-1. Cancer Biol. Ther. 7(3): 468475.
  • Huang Z, Chen G, Shi P. 2009. Effects of emodin on the gene expression profiling of human breast carcinoma cells. Cancer Detect. Prev. 32(4): 286291.
  • Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. 2011. Global cancer statistics. Cancer J. Clin. 61(2): 6990.
  • Jing X, Ueki N, Cheng J, Imanishi H, Hada T. 2002. Induction of apoptosis in hepatocellular carcinoma cell lines by emodin. Cancer Sci. 93(8): 874882.
  • Kabeer MA, Lloyd-Davies E, Maskell G, Hohle R, Mathew J. 2007. Metastatic prostate cancer masquerading clinically and radiologically as a primary caecal carcinoma. World J. Surg. Oncol. 5: 2.
  • Kaneshiro T, Morioka T, Inamine M, Kinjo T, Arakaki J, Chiba I, Sunagawa N, Suzui M, Yoshimi N. 2006. Anthraquinone derivative emodin inhibits tumor-associated angiogenesis through inhibition of extracellular signal-regulated kinase 1/2 phosphorylation. Eur. J. Pharmacol. 553(1–3): 4653.
  • Kawai N, Kunimatsu M, Tozawa K, Sasaki M, Kohri K. 2001. Human prostate cancer cells adhere specifically to hemoglobin: a possible role in bone-specific metastasis. Cancer Lett. 171(2): 2017.
  • Koong AC, Denko NC, Hudson KM, Schindler C, Swiersz L, Koch C, Evans S, Ibrahim H, Le QT, Terris DJ, Giaccia AJ. 2000. Candidate genes for the hypoxic tumor phenotype. Cancer Res. 60(4): 883887.
  • Kotamraju S, Konorev EA, Joseph J, Kalyanaraman B. 2000. Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen. Role of reactive oxygen and nitrogen species. J. Biol. Chem. 275(43): 3358533592.
  • Koyama J, Morita I, Tagahara K, Nobukuni Y, Mukainaka T, Kuchide M, Tokuda H, Nishino H. 2002. Chemopreventive effects of emodin and cassiamin B in mouse skin carcinogenesis. Cancer Lett. 182(2): 135139.
  • Kurbacher CM, Wagner U, Kolster B, Andreotti PE, Krebs D, Bruckner HW. 1996. Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin, and paclitaxel in human breast carcinoma cells in vitro. Cancer Lett. 103(2): 183189.
  • Lai JM, Chang JT, Wen CL, Hsu SL. 2009. Emodin induces a reactive oxygen species-dependent and ATM-p53-Bax mediated cytotoxicity in lung cancer cells. Eur. J. Pharmacol. 623(1–3): 19.
  • Lee HZ. 2001. Protein kinase C involvement in aloe-emodin- and emodin-induced apoptosis in lung carcinoma cell. Br. J. Pharmacol. 134(5): 10931103.
  • Lee NJ, Choi JH, Koo BS, Ryu SY, Han YH, Lee SI, Lee DU. 2005. Antimutagenicity and cytotoxicity of the constituents from the aerial parts of Rumex acetosa. Biol. Pharm. Bull. 28(11): 21582161.
  • Li Y, Wood N, Grimsley P, Yellowlees D, Donnelly PK. 1998. In vitro invasiveness of human breast cancer cells is promoted by low density lipoprotein receptor-related protein. Invasion Metastasis 18(5–6): 240251.
  • Lin SY, Lai WW, Ho CC, Yu FS, Chen GW, Yang JS, Liu KC, Lin ML, Wu PP, Fan MJ, Chung JG. 2009. Emodin induces apoptosis of human tongue squamous cancer SCC-4 cells through reactive oxygen species and mitochondria-dependent pathways. Anticancer Res. 29(1): 327335.
  • Lindner I, Hemdan NYA, Buchold M, Huse K, Bigl M, Oerlecke I, Ricken A, Gaunitz F, Sack U, Naumann A, Hollborn M, Thal D, Gebhardt R, Birkenmeier G. 2010. α2-Macroglobulin inhibits the malignant properties of astrocytoma cells by impeding β-catenin signaling. Cancer Res. 70(1): 277287.
  • Litwiniec A, Grzanka A, Helmin-Basa A, Gackowska L, Grzanka D. 2010. Features of senescence and cell death induced by doxorubicin in A549 cells: organization and level of selected cytoskeletal proteins. J. Cancer Res. Clin. Oncol. 136(5): 717736.
  • Masaldan S, Iyer VV. 2011. Antioxidant and antiproliferative activities of a methanolic extract of Aloe vera leaves in human cancer cell lines. J. Pharm. Res. 4(8): 27912796.
  • Montel V, Gaultier A, Lester RD, Campana WM, Gonias SL. 2007. The low-density lipoprotein receptor-related protein regulates cancer cell survival and metastasis development. Cancer Res. 67(20): 98179824.
  • Newton CS, Loukinova E, Mikhailenko I, Ranganathan S, Gao Y, Haudenschild C, Strickland DK. 2005. Platelet-derived growth factor receptor-β (PDGFR-β) activation promotes its association with the low density lipoprotein receptor-related protein (LRP). J. Biol. Chem. 280(30): 2787227878.
  • Park S-Y, Kim Y-J, Gao AC, Mohler JL, Onate SA, Hidalgo AA, Ip C, Park E-M, Yoon SY, Park Y-M. 2006. Hypoxia increases androgen receptor activity in prostate cancer cells. Cancer Res. 66(10): 51215129.
  • Piret J-P, Mottet D, Raes M, Michiels C. 2002. CoCl2, a chemical inducer of hypoxia-inducible factor-1, and hypoxia reduce apoptotic cell death in hepatoma cell line HepG2. Ann. N. Y. Acad. Sci. 973(1): 443447.
  • Reece KM, Troutman SM, Pressler HM, Pisle ST, Figg WD. 2012. Androgen receptor and HIF-1{alpha}cxc interaction in prostate cancer. ASCO Meeting Abstr. 30(5 suppl): 197.
  • Rietjens IM, Boersma MG, Haan L, Spenkelink B, Awad HM, Cnubben NH, van Zanden JJ, Woude H, Alink GM, Koeman JH. 2002. The pro-oxidant chemistry of the natural antioxidants vitamin C, vitamin E, carotenoids and flavonoids. Environ. Toxicol. Pharmacol. 11(3–4): 321333.
  • Saitoh H, Hida M, Shimbo T, Nakamura K, Yamagata J, Satoh T. 1984. Metastatic patterns of prostatic cancer. Correlation between sites and number of organs involved. Cancer 54(12): 30783084.
  • Shieh DE, Chen YY, Yen MH, Chiang LC, Lin CC. 2004. Emodin-induced apoptosis through p53-dependent pathway in human hepatoma cells. Life Sci. 74(18): 22792290.
  • Srinivas G, Anto RJ, Srinivas P, Vidhyalakshmi S, Senan VP, Karunagaran D. 2003. Emodin induces apoptosis of human cervical cancer cells through poly(ADP-ribose) polymerase cleavage and activation of caspase-9. Eur. J. Pharmacol. 473(2–3): 117125.
  • Su YJ, Tsai MS, Kuo YH, Chiu YF, Cheng CM, Lin ST, Lin YW. 2010. Role of Rad51 down-regulation and extracellular signal-regulated kinases 1 and 2 inactivation in emodin and mitomycin C-induced synergistic cytotoxicity in human non-small-cell lung cancer cells. Mol. Pharmacol. 77(4): 633643.
  • Su YT, Chang HL, Shyue SK, Hsu SL. 2005. Emodin induces apoptosis in human lung adenocarcinoma cells through a reactive oxygen species-dependent mitochondrial signaling pathway. Biochem. Pharmacol. 70(2): 229241.
  • Theyer G, Schirmbock M, Thalhammer T, Sherwood ER, Baumgartner G, Hamilton G. 1993. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines. J. Urol. 150(5 Pt 1): 15441547.
  • Wang W, Sun YP, Huang XZ, He M, Chen YY, Shi GY, Li H, Yi J, Wang J. 2010. Emodin enhances sensitivity of gallbladder cancer cells to platinum drugs via glutathion depletion and MRP1 downregulation. Biochem. Pharmacol. 79(8): 11341140.
  • Yamamoto M, Ikeda K, Ohshima K, Tsugu H, Kimura H, Tomonaga M. 1997. Increased expression of low density lipoprotein receptor-related protein/α2-macroglobulin receptor in human malignant astrocytomas. Cancer Res. 57(13): 27992805.
  • Yeole BB. 2008. Trends in the prostate cancer incidence in India. Asian Pac. J. Cancer Prev. 9(1): 141144.
  • Yim H, Lee YH, Lee CH, Lee SK. 1999. Emodin, an anthraquinone derivative isolated from the rhizomes of Rheum palmatum, selectively inhibits the activity of casein kinase II as a competitive inhibitor. Planta Med. 65(1): 913.
  • Yu CX, Zhang XQ, Kang LD, Zhang PJ, Chen WW, Liu WW, Liu QW, Zhang JY. 2008. Emodin induces apoptosis in human prostate cancer cell LNCaP. Asian J. Androl. 10(4): 625634.
  • Zhang L, Chang CJ, Bacus SS, Hung MC. 1995. Suppressed transformation and induced differentiation of HER-2/neu-overexpressing breast cancer cells by emodin. Cancer Res. 55(17): 38903896.
  • Zhou X, Song B, Jin L, Hu D, Diao C, Xu G, Zou Z, Yang S. 2006. Isolation and inhibitory activity against ERK phosphorylation of hydroxyanthraquinones from rhubarb. Bioorg. Med. Chem. Lett. 16(3): 563568.
  • Zubia M, Fabre MS, Kerjean V, Lann KL, Stiger-Pouvreau V, Fauchon M, Deslandes E. 2009. Antioxidant and antitumoural activities of some Phaeophyta from Brittany coasts. Food Chem. 116(3): 693701.